Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2026-09-08 16:30:03 ET · period of report 2026-09-03 · accession 0001193125-26-385250 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 16:30 | 2026-09-03 | PHAT | Breedlove Robert Charles | Principal Accounting Off | F - Tax | $9.05 | -460 | 59.5K | -0.8% | -$4,163 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-03 | F | D | 460 | $9.05 | 59,465 | D | — | — | (F1) Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation. |